Supernus Pharmaceuticals (NASDAQ: SUPN) has announced that it will be unveiling its third quarter financial results on Monday 4th November 2024. This eagerly anticipated announcement is scheduled to occur after market close, ensuring that investors and analysts have the opportunity to gain valuable insights into the company's performance during the quarter.
Financial analysts on Wall Street are predicting that the company is about to reveal an estimated $0.44 profit per share for the quarter. Additionally, the company is projected to announce a total revenue of $157.3 million for this period.
Wall Street analysts have revealed their forecasts for the company's annual performance, predicting a total revenue of $619.5 million. Additionally, they expect the company to report per share profit of $2.02 for the fiscal year.
In the previous year's corresponding quarter, the company's earnings report revealed a per-share loss of $0.29. Moreover, the company achieved a remarkable total revenue of $153.88 million during that quarter.
The business has scheduled a conference call on 4th November 2024 at 04:30 PM eastern time to discuss Q3 financial results.
Supernus Pharmaceuticals (SUPN) closed Friday's regular trading session at $33.97, marking a 0.29 percent fall, with a volume of 773.00 thousand shares.
